Morgan Stanley’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4
| Closed | -$88 | – | 8105 |
|
|
2023
Q4 | $88 | Buy |
4
+3
| +300% | +$66 | ﹤0.01% | 7504 |
|
|
2023
Q3 | $33 | Buy |
+1
| New | +$33 | ﹤0.01% | 7507 |
|
|
2022
Q3 | – | Sell |
-185
| Closed | -$4K | – | 7978 |
|
|
2022
Q2 | $4K | Hold |
185
| – | – | ﹤0.01% | 7475 |
|
|
2022
Q1 | $5K | Sell |
185
-90
| -33% | -$2.43K | ﹤0.01% | 7600 |
|
|
2021
Q4 | $10K | Buy |
275
+90
| +49% | +$3.27K | ﹤0.01% | 7474 |
|
|
2021
Q3 | $8K | Sell |
185
-176
| -49% | -$7.61K | ﹤0.01% | 7406 |
|
|
2021
Q2 | $14K | Buy |
361
+176
| +95% | +$6.83K | ﹤0.01% | 7142 |
|
|
2021
Q1 | $7K | Hold |
185
| – | – | ﹤0.01% | 7043 |
|
|
2020
Q4 | $6K | Buy |
+185
| New | +$6K | ﹤0.01% | 6754 |
|